Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents

Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript

Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents
Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript
Published Aug 09, 2021
19 pages (12018 words) — Published Aug 09, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of APLS.OQ earnings conference call or presentation 9-Aug-21 8:30pm GMT

  
Brief Excerpt:

...Operator Ladies and gentlemen, thank you for standing by, and welcome to Apellis Second Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions). I would now like to hand the conference over to your speaker host, Meredith Kaya, Senior Vice President of Investor Relations. Please go ahead. Meredith Kaya Good afternoon, and thank you for joining us to discuss Apellis' second quarter 2021 financial results. With me on the call are Co-Founder and Chief Executive Officer; Dr. Cedric Francois; Chief Commercial Officer, Adam Townsend; Chief Medical Officer, Dr. Federico Grossi; and Chief Financial Officer, Tim Sullivan. Before we begin, I would like to point out that we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Apellis Pharmaceuticals Inc
Ticker
APLS.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Eliana Rachel Merle - UBS Investment Bank, Research Division - Analyst : Just first, in terms of exudations in GA, and I guess maybe what we might know from the natural history around like how exudations might impact GA growth or just any associations we've seen historically either in your data or in the natural history. And then second question, just in terms of the commercial outlook for GA. Ex-U.S., I guess, just curious how you're thinking about potential commercial preparations ex-U.S. for GA and just any differences in terms of diagnosis rate or any particular maybe emphasis on endpoints versus the U.S. or anything different there in terms of the commercial strategy versus the U.S.? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 09, 2021 / 8:30PM, APLS.OQ - Q2 2021 Apellis Pharmaceuticals Inc Earnings Call

Question: Eliana Rachel Merle - UBS Investment Bank, Research Division - Analyst : Yes, really helpful.

Table Of Contents

Apellis Pharmaceuticals Inc Q4 2021 Earnings Call Transcript – 2022-02-28 – US$ 54.00 – Edited Transcript of APLS.OQ earnings conference call or presentation 28-Feb-22 9:30pm GMT

Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-10 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 10-Jan-22 1:15pm GMT

Apellis Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript – 2021-11-10 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 10-Nov-21 9:20pm GMT

Apellis Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-08 – US$ 54.00 – Edited Transcript of APLS.OQ earnings conference call or presentation 8-Nov-21 9:30pm GMT

Apellis Pharmaceuticals Inc Announces results from Phase 3 DERBY and OAKS Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of APLS.OQ conference call or presentation 9-Sep-21 8:30pm GMT

Apellis Pharmaceuticals Inc Research and Development Day - New York City and Virtually Transcript – 2021-06-30 – US$ 54.00 – Edited Transcript of APLS.OQ corporate analyst meeting</ 30-Jun-21 4:30pm GMT

Apellis Pharmaceuticals Inc at Bank of America NAPA Healthcare Conference Transcript – 2021-06-16 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 16-Jun-21 8:30pm GMT

Apellis Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-10 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 10-Jun-21 12:00pm GMT

Apellis Pharmaceuticals Inc EMPAVELI FDA Approval Call Transcript – 2021-05-17 – US$ 54.00 – Edited Transcript of APLS.OQ conference call or presentation 17-May-21 12:00pm GMT

Apellis Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-04-28 – US$ 54.00 – Edited Transcript of APLS.OQ earnings conference call or presentation 28-Apr-21 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript" Aug 09, 2021. Alacra Store. May 03, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Apellis-Pharmaceuticals-Inc-Earnings-Call-T14936227>
  
APA:
Thomson StreetEvents. (2021). Apellis Pharmaceuticals Inc Q2 2021 Earnings Call Transcript Aug 09, 2021. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Apellis-Pharmaceuticals-Inc-Earnings-Call-T14936227>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.